Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- befree-2016 importedOn "2016-02-19" NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion wasGeneratedBy ECO_0000203 NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion wasDerivedFrom befree-2016 NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion SIO_000772 23550022 NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion evidence source_evidence_literature NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion description "[Discovery of tyrosine kinase inhibitors targeting the BCR-ABL1 kinase revolutionized CML therapy, but these drugs are unable to eradicate the disease due to the presence of a drug-insensitive stem cell population that sustains continued growth of the malignant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.